Novacana2. Apr. 20201 Min.Novacana receives narcotic drug and AMRadV approvalWe are glad to announce that Novacana GmbH has received a narcotic drug license (German designation: BtM-Erlaubnis) approved by BfArM...
Novacana5. März 20202 Min.Access to the German MarketIn order to directly enter the German pharmaceutical market, a German entity with a Managing Director (MD) is required. As the German...
Novacana3. März 20202 Min.AMRadV - ComplianceWhat is AMRadV? The regulatory regime overseeing the distribution of a medicinal cannabis in Germany is continuously changing. Cannabis...
Novacana16. Jan. 20202 Min.EU-GMP vs GACPQualification of medical-grade cannabis In Europe, medical cannabis products must comply with the relevant requirements laid down in the...
Novacana15. Jan. 20204 Min.Guidelines for Export of Medical Cannabis from non-EU to GermanyThe following shall provide an overview of the regulatory steps necessary to import medical cannabis (MC) from non-EU countries to Germany
Novacana14. Jan. 20202 Min.German and EU market opportunityGermany There are medical cannabis supply deficiencies throughout the EU resulting from the limited number of cannabis producers that...